ANIK

Anika Therapeutics, Inc.

Latest Form 4:Purchase$21KbyFischetti Gary P (Director) · filed Aug 5, 2026

Anika Therapeutics, Inc. (ANIK) has 16 SEC Form 4 filings (35 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.

Insiders have net bought $264K over the trailing 6 months.

  • Industry:Medical - Specialties
  • CEO:Stephen D. Griffin
  • Employees:235
  • HQ:Bedford, MA, US
  • IPO:1993-05-03

Insider Buying

$264K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$282.4M

latest known value

Source
Fischetti Gary PFirst filing
Purchase$21KAug 5SEC ↗
Fischetti Gary PFirst filing
Purchase$20KAug 5SEC ↗
Purchase$73KMay 4SEC ↗
Griffin Stephen D.First filing
Purchase$150KApr 30SEC ↗

Related companies

Anika Therapeutics, Inc. is in the Healthcare sector.